Carbios SAS

Carbios SAS

ALCRB.PAPre-clinical
Saint-Beauzire, FranceFounded 2011carbios.com

Carbios is a publicly traded French biotechnology company developing and industrializing biological solutions to reinvent the life cycle of plastics and textiles. Its core technology leverages highly specific enzymes to depolymerize PET plastic waste into its core monomers, which can then be repolymerized into virgin-quality plastic, enabling true circularity. The company has established key partnerships with major industry players like L'Oréal, Nestlé Waters, and PepsiCo, and is advancing towards the operation of its first commercial reference plant. Carbios aims to license its technology globally to transform the plastics industry.

Market Cap
$149.2M
Founded
2011
Employees
50-100
Focus
Biotech

ALCRB.PA · Stock Price

USD 7.6621.36 (-73.59%)

Historical price data

AI Company Overview

Carbios is a publicly traded French biotechnology company developing and industrializing biological solutions to reinvent the life cycle of plastics and textiles. Its core technology leverages highly specific enzymes to depolymerize PET plastic waste into its core monomers, which can then be repolymerized into virgin-quality plastic, enabling true circularity. The company has established key partnerships with major industry players like L'Oréal, Nestlé Waters, and PepsiCo, and is advancing towards the operation of its first commercial reference plant. Carbios aims to license its technology globally to transform the plastics industry.

Technology Platform

Proprietary enzymatic processes for the depolymerization of PET plastic and polyester fibers into their core monomers, enabling infinite recycling and the production of virgin-quality recycled plastic.

Funding History

4

Total raised: $55.5M

PIPE$30MUndisclosedJun 15, 2020
Series A$8MUndisclosedJun 15, 2014
IPO$15MUndisclosedJul 3, 2013
Seed$2.5MUndisclosedJun 15, 2011

Opportunities

The global push for a circular economy and stringent regulations on plastic waste and recycled content create a massive, multi-billion euro market for Carbios' technology.
Licensing its proven process to global PET producers and brand owners offers a capital-light path to rapid scaling and significant recurring revenue streams.

Risk Factors

Key risks include the technical and financial challenges of scaling a novel bioprocess to full commercial capacity, competition from other recycling technologies, volatility in virgin plastic prices, and dependence on the execution capabilities of industrial partners like Indorama Ventures.

Competitive Landscape

Carbios competes with mechanical recyclers and thermochemical recycling companies (e.g., Loop Industries, Eastman). Its key differentiation is its enzymatic process, which operates at mild conditions, produces high-purity monomers suitable for food-grade packaging, and has a favorable environmental footprint, positioning it as a preferred solution for brand owners with ambitious sustainability goals.

Company Info

TypePlatform
Founded2011
Employees50-100
LocationSaint-Beauzire, France
StagePre-clinical
RevenuePre-revenue

Trading

TickerALCRB.PA
ExchangeEuronext Growth Paris

Contact

carbios.com+33 (0)4 73 86 51 76

Partners

L'OréalNestlé WatersPepsiCoSuntory Beverage & Food EuropeNovozymesIndorama VenturesToyo Seikan Group Holdings, Ltd.SalomonOnPatagonia
SIMILAR COMPANIES
4P-Pharma
4P-Pharma
Phase 2 · Lille
Patheon
Patheon
Pre-clinical · Lyon
ABL Diagnostics
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Adjuvatis
Pre-clinical · Lyon
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile